M&A Deal Summary

Wright Medical Group Acquires INBONE Technologies

On April 2, 2008, Wright Medical Group acquired medical products company INBONE Technologies for 24M USD

Acquisition Highlights
  • This is Wright Medical Group’s 4th transaction in the Medical Products sector.
  • This is Wright Medical Group’s 5th largest (disclosed) transaction.
  • This is Wright Medical Group’s 4th transaction in the United States.
  • This is Wright Medical Group’s 1st transaction in California.

M&A Deal Summary

Date 2008-04-02
Target INBONE Technologies
Sector Medical Products
Buyer(s) Wright Medical Group
Deal Type Add-on Acquisition
Deal Value 24M USD

Target

INBONE Technologies

Berkeley, California, United States
INBONE Technologies, Inc. is a manufacturer of INBONE Total Ankle System and the INBONE Intra-osseous Fusion Rod and Plate System.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Wright Medical Group

Arlington, Tennessee, United States

Category Company
Founded 1950
Sector Medical Products
Employees898
Revenue 242M USD (2013)
DESCRIPTION

Wright Medical Group, Inc. is an orthopedic medical device company specializing in the development and marketing of reconstructive joint devices and bio-orthopedics.


DEAL STATS #
Overall 4 of 8
Sector: Medical Products M&A 4 of 7
Type: Add-on Acquisition M&A Deals 3 of 7
State: California M&A 1 of 1
Country: United States M&A 4 of 7
Year: 2008 M&A 1 of 1
Size (of disclosed) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-22 MetaSurg BIO-ARCH Foot and Ankle Implant

Houston, Texas, United States

MetaSurg, BIO-ARCH Foot and Ankle Implant are used in surgical treatment of flatfoot deformity. The BIO-ARCH(TM) implant is innovatively designed to provide improved patient tolerance versus conventional implant designs and can be inserted in a fast, accurate and minimally invasive manner.

Buy $3M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-01 BioMimetic Therapeutics

Franklin, Tennessee, United States

BioMimetic Therapeutics, Inc. is a biotechnology company.

Buy $190M